News
The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine is sowing uncertainty about other ...
If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...
The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and ...
The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...
“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...
According to the WSJ, the universal vaccine project is being pioneered by two recently appointed senior scientists in the NIH ...
Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.
On a Thursday conference call with investors, Moderna CFO Jamey Mock outlined a roadmap for the mRNA specialist to lower its ...
21hOpinion
Medpage Today on MSNInside the FDA: Low Morale and Uncertainty Plague StaffSeveral current and former FDA employees who spoke to Inside Medicine on the condition of anonymity have come to see the ...
A major change in the way HHS plans to evaluate vaccine safety is raising fears that approvals will become unnecessarily ...
HHS Secretary Robert F. Kennedy Jr. wants to test all vaccines against a placebo but critics say it's not necessary as shots ...
Novavax’s COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company said Wednesday. The update sent Nova ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results